KLOW Peptide Australia: Buy the KLOW Stack Online

Shop the KLOW 80 mg Vial With Full Lot Data

Order KLOW when your protocol already uses all four compounds at this ratio, so one reconstitution and one certificate replace four of each. When any single component has to vary, buy the individual vials instead.

What Is KLOW Peptide?

KLOW peptide is a premixed research vial that holds four peptides in one blue cake: the copper tripeptide GHK-Cu, the alpha-MSH fragment KPV, the 15-residue BPC-157 and the thymosin beta-4 fragment TB-500. The K at the front marks KPV, the one component that the three-peptide GLOW vial does not contain, so the shortest answer to GHK-Cu vs KLOW peptide is that KLOW is GHK-Cu plus three partners.

Why these four are combined

Each ingredient comes from a separate line of research, and the blend is built to cover four steps of the repair cascade studied in skin and wound models. GHK-Cu, which Loren Pickart traced in human plasma during the 1970s, holds copper(II) tightly and is examined for collagen and matrix turnover in fibroblasts. KPV, the last three residues of alpha-MSH, is studied for damping NF-kappa B driven inflammation in epithelial cells. BPC-157 brings decades of rat tendon and gut injury work, much of it centred on blood vessel signalling. TB-500 represents the actin step that lets cells migrate. A model that tracks matrix, inflammation, vascular supply and migration together is the setting this vial was designed for.

KLOW research at a glance

• GHK-Cu: about 124 micromoles per vial.
• KPV: about 29 micromoles.
• TB-500: about 11 micromoles.
• BPC-157: about 7 micromoles.

Those numbers show something the milligram split hides. By molecule count, GHK-Cu outnumbers BPC-157 by roughly 18 to 1, and close to three quarters of every molecule in the solution is the copper peptide. In practice KLOW behaves as a copper peptide preparation with three minority partners, which is worth keeping in mind when a result is attributed to the blend as a whole.

No published paper has tested this exact four-way mixture, so any KLOW peptide benefits for skin reported so far come from the components studied one at a time, in fibroblast and keratinocyte cultures and rodent wound models, where collagen synthesis, cytokine release and wound closure speed are typical endpoints. Searches for KLOW peptide for skin research lead back to that same component literature. Each vial is a reagent, and the TGA has approved none of the four.

Our recommendation: run KLOW beside a GHK-Cu only arm at the same copper peptide concentration. Without that control, a skin or wound result from the blend cannot be separated from what GHK-Cu would have done alone. You will find KLOW among our premixed research blends and the skin and hair peptide range.

Buying KLOW Peptide in Australia: One Blue Vial, Four Regulatory Positions

Strip the marketing away and a KLOW order is one glass vial with a single blue cake inside: 50 mg of copper-bound GHK, then 10 mg apiece of KPV, BPC-157 and TB-500, all sharing the same 80 mg of powder. Nothing liquid comes with it, and no fifth compound or filler is listed on the label. The KLOW name is a supplier naming convention rather than a compound from the literature, so no paper or developer stands behind KLOW as such. Each ingredient brings its own history, and its own legal standing, into the vial.

Component by component

For a KLOW blend peptide GHK-Cu BPC-157 TB-500 KPV vial, the strictest ingredient sets the tone. BPC-157 entered Schedule 4 of the Poisons Standard on 1 June 2024, and thymosin beta-4 with its TB-500 fragment are also Schedule 4 (prescription only) listings. GHK-Cu was one of five peptides the TGA singled out by name in its April 2026 warning about unapproved peptide products that are not included on the ARTG. KPV has no approved therapeutic use here either. As of October 2026 not one of the four sits in any registered Australian medicine, and in sport WADA prohibits BPC-157 under S0 and TB-500 under S2.

That combination explains why KLOW peptide Australia searches lead only to research suppliers. AminoBlend holds the 80 mg vial in Australian stock as a laboratory reagent, for adults 18 and over to buy for in vitro work, and it is not for human or veterinary use. Labs that want to buy KLOW peptide Australia stock for a single variable study are better served by the KPV 10 mg vial on its own, and our GLOW and KLOW comparison shows what the extra component changes.

Order the KLOW Blend at a Lower Cost per mg Than Four Vials

Shop one fill, the 80 mg vial at $139, about $1.74 per mg of combined peptide. Bought as single vials, the same four compounds would mean a 50 mg GHK-Cu at $49, BPC-157 at $69, TB-500 at $79 and KPV at $59, which adds up to well over the price of one KLOW vial. The blend is therefore the economical route when all four already belong in your plan.

Order the vials for an entire series together and they come from one lot wherever stock allows, which keeps the four-way ratio consistent from first run to last and leaves a single certificate in the notebook. Purchase is restricted to adults aged 18 and over, confirmed at checkout.

Shop KLOW Peptide Australia Stock With Four Mass Matches on File

Testing a four-part blend asks more than testing one compound, because the report has to prove every component is there. Each lot certificate lists a mass match for GHK-Cu, KPV, BPC-157 and TB-500, together with an HPLC trace showing the separate peaks and the purity result. The blue colour is a second check, since copper bound to GHK-Cu tints both the cake and the solution, and a white cake sold under the KLOW name would point to a missing copper peptide.

Buy after finding your report under the lot code in our COA library. Because GHK-Cu makes up five eighths of the fill, its peak dominates the chromatogram, while the three 10 mg components show as smaller, well separated peaks that should all be present. That is also the fair way to judge which is the best KLOW blend on offer anywhere, since four published mass matches leave nothing to trust on faith.

Order KLOW Online and Store the Blue Vial

AminoBlend operates as an online store only, with no pickup point, and ships KLOW to every state and territory from Australian stock. Anything ordered ahead of the 3pm business-day cut-off goes out the same afternoon under tracking, so a lab ordering research peptides in Adelaide and one in Townsville receive the same lot-tracked stock.

Buy bacteriostatic water with it, bring the vial to room temperature and let the liquid run down the glass before swirling. Because the fill is large, a bigger volume is practical. Adding 4 mL to the 80 mg vial gives 20 mg/mL in total, which is 12.5 mg/mL of GHK-Cu and 2.5 mg/mL each of KPV, BPC-157 and TB-500. The reconstitution calculator works out the total for any volume, and the fixed split does the rest.

Hold sealed vials at -20 °C in their box. Keep the blue solution at 2 to 8 °C, divided into aliquots and protected from light, and do not refreeze it.

Other Names for the KLOW Blend Peptides

The same vial appears as KLOW, KLOW stack, KLOW 80 peptide, KLOW blend peptide or the KLOW copper peptide blend, and some catalogues spell out GHK-Cu, KPV, BPC-157 and TB-500 in full. All of these describe the four compounds above in a 50 to 10 to 10 to 10 ratio.

Its vocabulary is borrowed from the components, with copper tripeptide-1 and glycyl-histidyl-lysine for GHK-Cu, alpha-MSH (11-13) for KPV, body protection compound for BPC-157, and thymosin beta-4 fragment for TB-500.

Buy KLOW or GLOW, and GHK-Cu vs KLOW Peptide

GLOW is a 70 mg vial at $129 holding GHK-Cu, BPC-157 and TB-500 at 50 to 10 to 10. KLOW keeps those three and adds 10 mg of KPV for a modest step up in price. Order KLOW when inflammatory signalling in epithelial cells is part of the question, otherwise GLOW covers the same ground with one fewer variable. The GLOW vs KLOW guide compares the two fills in detail.

Shop single GHK-Cu when copper peptide work is the whole study, since a blend adds three more variables you may not want. For only the two repair peptides, the Wolverine Blend is the simpler choice.